Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Pancreatic Cancer × apatinib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 55 Carcinoma, Hepatocellular 41 Colorectal Neoplasms 16 Esophageal Squamous Cell Carcinoma 10 Cholangiocarcinoma 10 Esophageal Neoplasms 9 Advanced Gastric Cancer 8 Pancreatic Neoplasms 6 Biliary Tract Neoplasms 6 Liver Neoplasms 5 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Gastric Adenocarcinoma 2 Locally Advanced Gastric Cancer 2 Gastrointestinal Stromal Tumors 2 Advanced Esophagus Cancer 2 Uterine Cervical Neoplasms 1 Stomach Diseases 1 Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence 1 Peritoneal Metastases From Gastric Cancer 1 Ovarian Neoplasms 1 Locally Advanced or Metastatic Gastric Adenocarcinoma 1 Intestinal Neoplasms 1 Immunotherapy 1 Hepatic Metastasis of Colorectal Cancer 1 HER-2 Negatived Gastric Cancer 1 Gastric Cancer With Positive Exfoliative Cancer Cells 1

Interventions

Gemcitabine 7 S 1 (combination) 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 toripalimab 3 Taxes 3 Nivolumab 2 Injections 2 Drug Therapy 2 penpulimab 1 pegylated granulocyte colony-stimulating factor 1 nimotuzumab 1 irinotecan sucrosofate 1 gimeracil 1 fluzoparib 1 envafolimab 1 endostar protein 1 conteltinib 1 cabiralizumab 1 apatinib 1 Tegafur 1 Simvastatin 1 Radiosurgery 1 Paclitaxel 1 Oxaliplatin 1 Metformin 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03662035 2018-09-19

ASPC

Changzhou No.2 People's Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡